Ramzi Amri
Chief Financial Officer Oncoinvent AS
Seminars
Tuesday 21st July 2026
Roundtable Discussion – Designing Effective TRP Targets by Exploring Emerging Clinical Candidates & Lessons from Other Targeted Therapies
10:00 am
Join your colleagues for a deep-dive discussion in smaller groups to map out the next generation of TRP targets. You will brainstorm high-potential clinical candidates and cross-pollinate ideas from the ADC space to sharpen selection strategy before sharing your table’s thoughts and discussion back to the group.
- Identifying optimal tumor targets by evaluating density, internalization, and off-target risk
- Exploring current targets under development and their potential clinical impact
- Applying lessons from antibody-drug conjugates and other targeted therapies to guide RLT target selection
Wednesday 22nd July 2026
Beyond Systemic RLT: Phase 2 Evidence of Local Alpha Therapy to Prevent Peritoneal Recurrence
4:30 pm
- Limitations of systemic radioligand therapies in addressing microscopic peritoneal disease
- Scientific and clinical rationale for intraperitoneal delivery of alpha-emitting radiopharmaceuticals
- Development strategy for Radspherin® targeting prevention of peritoneal recurrence following surgery
